|
OMIM |
Link |
Information gain |
01 |
|
TH
|
[NCBI]
|
0.00186191
|
|
|
behr syndrome
|
[NCBI]
|
0.00181547
|
|
|
BDNF
|
[NCBI]
|
0.00146341
|
|
|
NGFB
|
[NCBI]
|
0.00106297
|
|
|
AD
|
[NCBI]
|
0.00105902
|
|
|
GFAP
|
[NCBI]
|
0.00103109
|
|
|
CHAT
|
[NCBI]
|
0.00101927
|
|
|
CMT2G
|
[NCBI]
|
0.000832846
|
|
|
spinocerebellar ataxia with rigidity and peripheral neuropathy
|
[NCBI]
|
0.000832846
|
|
|
pallidopyramidal syndrome
|
[NCBI]
|
0.000832846
|
|
|
auditory neuropathy, autosomal dominant, 1
|
[NCBI]
|
0.000750767
|
|
|
GDNF
|
[NCBI]
|
0.000711713
|
|
|
RA
|
[NCBI]
|
0.000690937
|
|
|
HCFP1
|
[NCBI]
|
0.000657993
|
|
|
PD
|
[NCBI]
|
0.000646725
|
|
|
CNTF
|
[NCBI]
|
0.000629233
|
|
|
CLN4B
|
[NCBI]
|
0.000600386
|
|
|
SCAX1
|
[NCBI]
|
0.000600386
|
|
|
FTD
|
[NCBI]
|
0.000526051
|
|
|
WDM
|
[NCBI]
|
0.000475624
|
|
|
SMAX1
|
[NCBI]
|
0.000461254
|
|
|
SLE
|
[NCBI]
|
0.000448494
|
|
|
SOD1
|
[NCBI]
|
0.000352401
|
|
|
MBS
|
[NCBI]
|
0.000352107
|
|
|
MJD
|
[NCBI]
|
0.000350142
|
|
|
ACHE
|
[NCBI]
|
0.000343134
|
|
|
DRPLA
|
[NCBI]
|
0.000295792
|
|
|
SPS
|
[NCBI]
|
0.000289175
|
|
|
ALS1
|
[NCBI]
|
0.000272424
|
|
|
CF
|
[NCBI]
|
0.000267644
|
|
|
OMP
|
[NCBI]
|
0.000248451
|
|
|
pick disease of brain
|
[NCBI]
|
0.000220895
|
|
|
HD
|
[NCBI]
|
0.000217514
|
|
|
EGFR
|
[NCBI]
|
0.000183931
|
|
|
krabbe disease
|
[NCBI]
|
0.000179656
|
|
|
MAP2
|
[NCBI]
|
0.000159549
|
|
|
SNCA
|
[NCBI]
|
0.000153787
|
|
|
VEGF
|
[NCBI]
|
0.000147362
|
|
|
FFI
|
[NCBI]
|
0.0001448
|
|
|
MAPT
|
[NCBI]
|
0.000144621
|
|
|
PSNP1
|
[NCBI]
|
0.000131402
|
|
|
APOE
|
[NCBI]
|
0.000130758
|
|
|
CJD
|
[NCBI]
|
0.000128654
|
|
|
gliosis, familial progressive subcortical
|
[NCBI]
|
0.000125554
|
|
|
CDK5
|
[NCBI]
|
0.000124465
|
|
|
MPO
|
[NCBI]
|
0.000113591
|
|
|
PARK4
|
[NCBI]
|
0.000110333
|
|
|
SLC6A3
|
[NCBI]
|
0.000110257
|
|
|
SCA1
|
[NCBI]
|
0.000107298
|
|
|
EGF
|
[NCBI]
|
0.000104123
|
|
|
spinocerebellar ataxia, 16q22-linked
|
[NCBI]
|
0.000103168
|
|
|
PRL
|
[NCBI]
|
9.68538e-05
|
|
|
cerebellar degeneration-related autoantigen 3
|
[NCBI]
|
9.36023e-05
|
|
|
HMN2B
|
[NCBI]
|
9.36023e-05
|
|
|
ataxia with myoclonic epilepsy and presenile dementia
|
[NCBI]
|
9.36023e-05
|
|
|
skeletal dysplasia and progressive central nervous system degeneration, lethal
|
[NCBI]
|
9.36023e-05
|
|
|
CMT4J
|
[NCBI]
|
9.36023e-05
|
|
|
AMC
|
[NCBI]
|
8.42395e-05
|
|
|
HCRT
|
[NCBI]
|
8.41554e-05
|
|
|
PNPLA6
|
[NCBI]
|
8.21885e-05
|
|
|
MAP3K5
|
[NCBI]
|
8.19968e-05
|
|
|
AGS1
|
[NCBI]
|
8.11562e-05
|
|
|
GALR2
|
[NCBI]
|
8.08369e-05
|
|
|
PARK2
|
[NCBI]
|
7.67442e-05
|
|
|
PPT1
|
[NCBI]
|
7.46759e-05
|
|
|
GRID2
|
[NCBI]
|
7.23236e-05
|
|
|
cerebrocortical degeneration of infancy
|
[NCBI]
|
7.118e-05
|
|
|
spinocerebellar ataxia, x-linked 3
|
[NCBI]
|
7.118e-05
|
|
|
dystonia, juvenile-onset
|
[NCBI]
|
7.118e-05
|
|
|
spinal muscular atrophy, scapuloperoneal
|
[NCBI]
|
7.118e-05
|
|
|
beta-hydroxyisobutyryl coa deacylase, deficiency of
|
[NCBI]
|
7.118e-05
|
|
|
HSPB1
|
[NCBI]
|
7.00136e-05
|
|
|
MAP1B
|
[NCBI]
|
6.83201e-05
|
|
|
NRCLP1
|
[NCBI]
|
6.55643e-05
|
|
|
DRPLA
|
[NCBI]
|
6.52177e-05
|
|
|
AT
|
[NCBI]
|
6.47363e-05
|
|
|
TGD
|
[NCBI]
|
6.46464e-05
|
|
|
PCNA
|
[NCBI]
|
6.29627e-05
|
|
|
OPTB4
|
[NCBI]
|
6.27482e-05
|
|
|
charcot-marie-tooth disease, axonal, type 2f
|
[NCBI]
|
6.27482e-05
|
|
|
optic atrophy, hearing loss, and peripheral neuropathy, autosomal recessive
|
[NCBI]
|
6.27482e-05
|
|
|
neuronal intranuclear inclusion disease
|
[NCBI]
|
6.27482e-05
|
|
|
ataxia-deafness-retardation syndrome
|
[NCBI]
|
6.27482e-05
|
|
|
PDCD8
|
[NCBI]
|
6.05172e-05
|
|
|
SPG3A
|
[NCBI]
|
6.0448e-05
|
|
|
ZS
|
[NCBI]
|
5.94195e-05
|
|
|
RP
|
[NCBI]
|
5.74457e-05
|
|
|
adie pupil
|
[NCBI]
|
5.72902e-05
|
|
|
hypoprebetalipoproteinemia, acanthocytosis, retinitis pigmentosa, and pallidal degeneration
|
[NCBI]
|
5.72902e-05
|
|
|
charcot-marie-tooth disease, recessive intermediate a
|
[NCBI]
|
5.72902e-05
|
|
|
TNF
|
[NCBI]
|
5.67261e-05
|
|
|
SCA6
|
[NCBI]
|
5.54462e-05
|
|
|
DFNA17
|
[NCBI]
|
5.32446e-05
|
|
|
schindler disease, type i
|
[NCBI]
|
5.32446e-05
|
|
|
BAG5
|
[NCBI]
|
4.98714e-05
|
|
|
ELAVL2
|
[NCBI]
|
4.98714e-05
|
|
|
DNAJC7
|
[NCBI]
|
4.98714e-05
|
|
|
AGTPBP1
|
[NCBI]
|
4.98714e-05
|
|
|
HTR4
|
[NCBI]
|
4.98714e-05
|
|
|
ARFIP2
|
[NCBI]
|
4.98714e-05
|
|
|
SV2B
|
[NCBI]
|
4.98714e-05
|
|
|
kiaa0274
|
[NCBI]
|
4.98714e-05
|
|
|
NPEPPS
|
[NCBI]
|
4.98714e-05
|
|
|
SCA7
|
[NCBI]
|
4.95698e-05
|
|
|
HGF
|
[NCBI]
|
4.90592e-05
|
|
|
ACCN2
|
[NCBI]
|
4.85008e-05
|
|
|
EAD
|
[NCBI]
|
4.73668e-05
|
|
|
CLCN7
|
[NCBI]
|
4.66661e-05
|
|
|
AVP
|
[NCBI]
|
4.57081e-05
|
|
|
GRIA2
|
[NCBI]
|
4.3469e-05
|
|
|
ATXN7
|
[NCBI]
|
4.3469e-05
|
|
|
CFTR
|
[NCBI]
|
4.34661e-05
|
|
|
LIS1
|
[NCBI]
|
4.31121e-05
|
|
|
spinal muscular atrophy, proximal, adult, autosomal dominant
|
[NCBI]
|
4.31121e-05
|
|
|
scapuloperoneal syndrome, neurogenic, kaeser type
|
[NCBI]
|
4.13576e-05
|
|
|
SPG11
|
[NCBI]
|
4.13576e-05
|
|
|
leber optic atrophy
|
[NCBI]
|
4.11924e-05
|
|
|
SCA2
|
[NCBI]
|
3.99305e-05
|
|
|
SPG6
|
[NCBI]
|
3.97842e-05
|
|
|
CMT2A2
|
[NCBI]
|
3.97842e-05
|
|
|
SMA1
|
[NCBI]
|
3.88575e-05
|
|
|
SLC16A1
|
[NCBI]
|
3.83913e-05
|
|
|
liddle syndrome
|
[NCBI]
|
3.83588e-05
|
|
|
G6PD
|
[NCBI]
|
3.74738e-05
|
|
|
MG
|
[NCBI]
|
3.70775e-05
|
|
|
PARK1
|
[NCBI]
|
3.70567e-05
|
|
|
SNDI
|
[NCBI]
|
3.70567e-05
|
|
|
CMT2A1
|
[NCBI]
|
3.70567e-05
|
|
|
DST
|
[NCBI]
|
3.63096e-05
|
|
|
PAWR
|
[NCBI]
|
3.61567e-05
|
|
|
HIBCH
|
[NCBI]
|
3.61567e-05
|
|
|
DNAJB1
|
[NCBI]
|
3.61567e-05
|
|
|
MAFG
|
[NCBI]
|
3.61567e-05
|
|
|
DYNC1H1
|
[NCBI]
|
3.61567e-05
|
|
|
ZNF259
|
[NCBI]
|
3.61567e-05
|
|
|
SEMA4D
|
[NCBI]
|
3.61567e-05
|
|
|
DSMA1
|
[NCBI]
|
3.47503e-05
|
|
|
MTS
|
[NCBI]
|
3.37192e-05
|
|
|
PANK2
|
[NCBI]
|
3.35906e-05
|
|
|
myasthenic syndrome, congenital, associated with episodic apnea
|
[NCBI]
|
3.27557e-05
|
|
|
alpers diffuse degeneration of cerebral gray matter with hepatic cirrhosis
|
[NCBI]
|
3.27557e-05
|
|
|
PINK1
|
[NCBI]
|
3.19915e-05
|
|
|
LPL
|
[NCBI]
|
3.19253e-05
|
|
|
tibial muscular dystrophy, tardive
|
[NCBI]
|
3.1852e-05
|
|
|
HSAN2
|
[NCBI]
|
3.1852e-05
|
|
|
SLC18A2
|
[NCBI]
|
3.12455e-05
|
|
|
PRDM2
|
[NCBI]
|
3.10213e-05
|
|
|
AP3B2
|
[NCBI]
|
3.10213e-05
|
|
|
CDR2
|
[NCBI]
|
3.10213e-05
|
|
|
jtv1 gene
|
[NCBI]
|
3.10213e-05
|
|
|
GLUD2
|
[NCBI]
|
3.10213e-05
|
|
|
RAB1
|
[NCBI]
|
3.10213e-05
|
|
|
PPT2
|
[NCBI]
|
3.10213e-05
|
|
|
SNN
|
[NCBI]
|
3.10213e-05
|
|
|
MAFK
|
[NCBI]
|
3.10213e-05
|
|
|
GAPDHS
|
[NCBI]
|
3.10213e-05
|
|
|
ICAM5
|
[NCBI]
|
3.10213e-05
|
|
|
ELAVL3
|
[NCBI]
|
3.10213e-05
|
|
|
alpha-ketoglutarate dehydrogenase deficiency
|
[NCBI]
|
3.10213e-05
|
|
|
FTLDU
|
[NCBI]
|
3.10013e-05
|
|
|
PARK8
|
[NCBI]
|
3.01981e-05
|
|
|
alexander disease
|
[NCBI]
|
3.01981e-05
|
|
|
DLB
|
[NCBI]
|
2.94376e-05
|
|
|
diabetes insipidus, neurohypophyseal type
|
[NCBI]
|
2.87157e-05
|
|
|
NGFR
|
[NCBI]
|
2.85114e-05
|
|
|
GSD
|
[NCBI]
|
2.8029e-05
|
|
|
EAOH
|
[NCBI]
|
2.8029e-05
|
|
|
CTF1
|
[NCBI]
|
2.77095e-05
|
|
|
COLQ
|
[NCBI]
|
2.77095e-05
|
|
|
ELAVL4
|
[NCBI]
|
2.77095e-05
|
|
|
PITPN
|
[NCBI]
|
2.77095e-05
|
|
|
GRIN2A
|
[NCBI]
|
2.77095e-05
|
|
|
CYCS
|
[NCBI]
|
2.77095e-05
|
|
|
STXBP1
|
[NCBI]
|
2.77095e-05
|
|
|
NPTX2
|
[NCBI]
|
2.77095e-05
|
|
|
NOVA1
|
[NCBI]
|
2.77095e-05
|
|
|
TRPM7
|
[NCBI]
|
2.77095e-05
|
|
|
USH2A
|
[NCBI]
|
2.73743e-05
|
|
|
PDE6B
|
[NCBI]
|
2.73628e-05
|
|
|
GAN1
|
[NCBI]
|
2.6749e-05
|
|
|
canavan disease
|
[NCBI]
|
2.6749e-05
|
|
|
SLC18A3
|
[NCBI]
|
2.57237e-05
|
|
|
PMD
|
[NCBI]
|
2.55857e-05
|
|
|
ALMS
|
[NCBI]
|
2.55775e-05
|
|
|
SEPT5
|
[NCBI]
|
2.52638e-05
|
|
|
ACTB
|
[NCBI]
|
2.52638e-05
|
|
|
CNP
|
[NCBI]
|
2.52638e-05
|
|
|
CASP2
|
[NCBI]
|
2.52638e-05
|
|
|
GCSH
|
[NCBI]
|
2.52638e-05
|
|
|
APP
|
[NCBI]
|
2.38817e-05
|
|
|
thrombocytopenic purpura, autoimmune
|
[NCBI]
|
2.38107e-05
|
|
|
NPY
|
[NCBI]
|
2.35398e-05
|
|
|
RP3
|
[NCBI]
|
2.34998e-05
|
|
|
NIPA1
|
[NCBI]
|
2.33282e-05
|
|
|
RGMA
|
[NCBI]
|
2.33282e-05
|
|
|
HSPA1A
|
[NCBI]
|
2.33282e-05
|
|
|
MSS
|
[NCBI]
|
2.30272e-05
|
|
|
OPA1
|
[NCBI]
|
2.30272e-05
|
|
|
myoclonic epilepsy of lafora
|
[NCBI]
|
2.25709e-05
|
|
|
KSS
|
[NCBI]
|
2.20166e-05
|
|
|
SIL1
|
[NCBI]
|
2.17298e-05
|
|
|
KCNJ6
|
[NCBI]
|
2.17298e-05
|
|
|
CRLF1
|
[NCBI]
|
2.17298e-05
|
|
|
TGM2
|
[NCBI]
|
2.17298e-05
|
|
|
CLDN14
|
[NCBI]
|
2.17298e-05
|
|
|
mitochondrial complex iv deficiency
|
[NCBI]
|
2.12906e-05
|
|
|
ODDD
|
[NCBI]
|
2.12906e-05
|
|
|
PRPH
|
[NCBI]
|
2.03708e-05
|
|
|
GNAQ
|
[NCBI]
|
2.03708e-05
|
|
|
PRND
|
[NCBI]
|
2.03708e-05
|
|
|
UBB
|
[NCBI]
|
2.03708e-05
|
|
|
CLU
|
[NCBI]
|
2.01429e-05
|
|
|
NEFH
|
[NCBI]
|
1.9191e-05
|
|
|
SLC1A3
|
[NCBI]
|
1.9191e-05
|
|
|
ALMS1
|
[NCBI]
|
1.9191e-05
|
|
|
MAPK7
|
[NCBI]
|
1.9191e-05
|
|
|
IGHMBP2
|
[NCBI]
|
1.9191e-05
|
|
|
TNFSF6
|
[NCBI]
|
1.83072e-05
|
|
|
APAF1
|
[NCBI]
|
1.81503e-05
|
|
|
SNCG
|
[NCBI]
|
1.81503e-05
|
|
|
ATRN
|
[NCBI]
|
1.81503e-05
|
|
|
SETX
|
[NCBI]
|
1.81503e-05
|
|
|
GSK3B
|
[NCBI]
|
1.81503e-05
|
|
|
NRG1
|
[NCBI]
|
1.78442e-05
|
|
|
PRNP
|
[NCBI]
|
1.72769e-05
|
|
|
SEMA3A
|
[NCBI]
|
1.72206e-05
|
|
|
CD4
|
[NCBI]
|
1.72206e-05
|
|
|
PSIP1
|
[NCBI]
|
1.72206e-05
|
|
|
CREB1
|
[NCBI]
|
1.72206e-05
|
|
|
hypertrophic neuropathy of dejerine-sottas
|
[NCBI]
|
1.6887e-05
|
|
|
MAPK8
|
[NCBI]
|
1.63817e-05
|
|
|
DHH
|
[NCBI]
|
1.63817e-05
|
|
|
GAL3ST1
|
[NCBI]
|
1.63817e-05
|
|
|
adrenoleukodystrophy, autosomal neonatal form
|
[NCBI]
|
1.58038e-05
|
|
|
DLL3
|
[NCBI]
|
1.56184e-05
|
|
|
myoclonic epilepsy of unverricht and lundborg
|
[NCBI]
|
1.55483e-05
|
|
|
GLUD1
|
[NCBI]
|
1.4919e-05
|
|
|
NEFL
|
[NCBI]
|
1.4919e-05
|
|
|
CMT1B
|
[NCBI]
|
1.4815e-05
|
|
|
alsin
|
[NCBI]
|
1.42744e-05
|
|
|
DLD
|
[NCBI]
|
1.42744e-05
|
|
|
NR4A2
|
[NCBI]
|
1.42744e-05
|
|
|
GDAP1
|
[NCBI]
|
1.42744e-05
|
|
|
ATXN3
|
[NCBI]
|
1.42744e-05
|
|
|
ABL
|
[NCBI]
|
1.39077e-05
|
|
|
RSTS
|
[NCBI]
|
1.36923e-05
|
|
|
SSTR2
|
[NCBI]
|
1.36772e-05
|
|
|
LPO
|
[NCBI]
|
1.36772e-05
|
|
|
SCNN1B
|
[NCBI]
|
1.36772e-05
|
|
|
CYP2D6
|
[NCBI]
|
1.36772e-05
|
|
|
GRB2
|
[NCBI]
|
1.36772e-05
|
|
|
PNMT
|
[NCBI]
|
1.35243e-05
|
|
|
CRH
|
[NCBI]
|
1.34153e-05
|
|
|
GAPDH
|
[NCBI]
|
1.33793e-05
|
|
|
LIFR
|
[NCBI]
|
1.31216e-05
|
|
|
RIPK1
|
[NCBI]
|
1.31216e-05
|
|
|
LRRK2
|
[NCBI]
|
1.28995e-05
|
|
|
MBP
|
[NCBI]
|
1.26837e-05
|
|
|
CXCL12
|
[NCBI]
|
1.21161e-05
|
|
|
PENK
|
[NCBI]
|
1.16587e-05
|
|
|
DDIT3
|
[NCBI]
|
1.16587e-05
|
|
|
ADORA3
|
[NCBI]
|
1.16587e-05
|
|
|
DFFB
|
[NCBI]
|
1.16587e-05
|
|
|
SMN1
|
[NCBI]
|
1.15645e-05
|
|
|
PTHLH
|
[NCBI]
|
1.1408e-05
|
|
|
REST
|
[NCBI]
|
1.12275e-05
|
|
|
MYH9
|
[NCBI]
|
1.12275e-05
|
|
|
porphyria variegata
|
[NCBI]
|
1.1073e-05
|
|
|
CLN3
|
[NCBI]
|
1.082e-05
|
|
|
CAT
|
[NCBI]
|
1.04663e-05
|
|
|
HDGF
|
[NCBI]
|
1.0434e-05
|
|
|
apnea, obstructive sleep
|
[NCBI]
|
9.77806e-06
|
|
|
PTK2B
|
[NCBI]
|
9.71949e-06
|
|
|
ATXN1
|
[NCBI]
|
9.71949e-06
|
|
|
PTK2
|
[NCBI]
|
9.57852e-06
|
|
|
menkes disease
|
[NCBI]
|
9.4225e-06
|
|
|
SLC1A2
|
[NCBI]
|
9.38781e-06
|
|
|
TGFBR2
|
[NCBI]
|
9.38781e-06
|
|
|
DAP
|
[NCBI]
|
9.07143e-06
|
|
|
PARG
|
[NCBI]
|
9.07143e-06
|
|
|
MTND1
|
[NCBI]
|
8.76923e-06
|
|
|
CSTB
|
[NCBI]
|
8.48018e-06
|
|
|
TLR3
|
[NCBI]
|
8.20339e-06
|
|
|
NPC1
|
[NCBI]
|
8.20339e-06
|
|
|
ATF3
|
[NCBI]
|
7.93803e-06
|
|
|
DDC
|
[NCBI]
|
7.68336e-06
|
|
|
GSN
|
[NCBI]
|
7.43872e-06
|
|
|
GLB1
|
[NCBI]
|
7.2035e-06
|
|
|
ERBB2
|
[NCBI]
|
7.2035e-06
|
|
|
GAL
|
[NCBI]
|
7.16826e-06
|
|
|
XDH
|
[NCBI]
|
7.14599e-06
|
|
|
amyloidosis vi
|
[NCBI]
|
6.59044e-06
|
|
|
AR
|
[NCBI]
|
6.47203e-06
|
|
|
FRAP1
|
[NCBI]
|
6.4019e-06
|
|
|
LRP1
|
[NCBI]
|
6.2258e-06
|
|
|
FRDA
|
[NCBI]
|
6.10807e-06
|
|
|
SMN2
|
[NCBI]
|
5.77949e-06
|
|
|
ANG
|
[NCBI]
|
5.43243e-06
|
|
|
TTR
|
[NCBI]
|
5.42246e-06
|
|
|
TLR4
|
[NCBI]
|
5.01787e-06
|
|
|
MMP2
|
[NCBI]
|
4.95255e-06
|
|
|
VIP
|
[NCBI]
|
4.84605e-06
|
|
|
RP2
|
[NCBI]
|
4.65704e-06
|
|
|
GNRH1
|
[NCBI]
|
4.41642e-06
|
|
|
BCL2
|
[NCBI]
|
4.37917e-06
|
|
|
BIRC1
|
[NCBI]
|
4.37917e-06
|
|
|
PSEN1
|
[NCBI]
|
4.35723e-06
|
|
|
MSH2
|
[NCBI]
|
4.24641e-06
|
|
|
SHH
|
[NCBI]
|
4.01569e-06
|
|
|
POMC
|
[NCBI]
|
3.87271e-06
|
|
|
PEDF
|
[NCBI]
|
3.6103e-06
|
|
|
OXT
|
[NCBI]
|
3.21067e-06
|
|
|
ABCD1
|
[NCBI]
|
2.7389e-06
|
|
|
PTGS2
|
[NCBI]
|
2.7389e-06
|
|
|
ALD
|
[NCBI]
|
2.42136e-06
|
|
|
UCP2
|
[NCBI]
|
2.32707e-06
|
|
|
CCK
|
[NCBI]
|
2.05617e-06
|
|
|
SRF
|
[NCBI]
|
1.96683e-06
|
|
|
VIM
|
[NCBI]
|
1.71124e-06
|
|
|
CHS
|
[NCBI]
|
1.54398e-06
|
|
|
EPO
|
[NCBI]
|
1.39226e-06
|
|
|
MAG
|
[NCBI]
|
1.32303e-06
|
|
|
SLC6A4
|
[NCBI]
|
1.27517e-06
|
|
|
MPZ
|
[NCBI]
|
1.18011e-06
|
|
|
STAT3
|
[NCBI]
|
8.53404e-07
|
|
|
CP
|
[NCBI]
|
7.85029e-07
|
|
|
PMCH
|
[NCBI]
|
5.56913e-07
|
|
|
COMT
|
[NCBI]
|
5.42965e-07
|
|
|
SOD2
|
[NCBI]
|
4.73576e-07
|
|
|
BCHE
|
[NCBI]
|
3.80945e-07
|
|
|
CDK4
|
[NCBI]
|
3.80945e-07
|
|
|
MDD
|
[NCBI]
|
3.34901e-07
|
|
|
CCND1
|
[NCBI]
|
2.98015e-07
|
|
|
SST
|
[NCBI]
|
2.43561e-07
|
|
|
ADCYAP1
|
[NCBI]
|
7.6323e-08
|
|
|
GJA1
|
[NCBI]
|
6.01101e-08
|
|
|
AKR1B1
|
[NCBI]
|
1.40671e-08
|
|
|
panencephalitis, subacute sclerosing
|
[NCBI]
|
1.3959e-08
|
|
|
SPP1
|
[NCBI]
|
7.26853e-09
|
|